Valproic Acid Solution
Product Images NDC 70518-3805

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 70518-3805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label of Valproic Acid 250 mg/5 mL oral solution in 10 individual 5 mL cups. The label includes the proprietary name, strength, dosage form, and quantity. It also states the product is RX only, provides the NDC number 70518-3805-00, manufacturer information, storage instructions, and repackaging details by RemedyRepack Inc.*
FDA Label Image

Mm2 (Valproic Acid 250mg 5ml 70518 3805 01)

Mm2 (Valproic Acid 250mg   5ml 70518 3805 01)
Label for Valproic Acid 250 mg/5 mL oral solution, 5 mL quantity. The label includes the brand RemedyRepack and states it is RX only. Manufacturer is Pharmaceutical Associates, Greenville, SC. Contains storage instructions and repackaging information by RemedyRepack Inc., Indiana, PA.*
FDA Label Image

Chemical Structure (Valproic Acid 1)

Chemical Structure (Valproic Acid 1)
Chemical structure of valproic acid showing its molecular arrangement with carbon, hydrogen, and oxygen atoms forming a branched chain carboxylic acid.*
FDA Label Image

Figure 1 (Valproic Acid 2)

Figure 1 (Valproic Acid 2)
A graph depicting the percentage reduction in CPS Rate versus percentage of patients, comparing Divalproex Sodium and placebo. The Y-axis measures % reduction in CPS Rate from -100% to 100%, with improvement indicated upwards and worsening downwards. The X-axis shows % of patients from 0 to 100. Two curves are shown: a solid line for Divalproex Sodium and a dashed line for placebo.*
FDA Label Image

Figure 2 (Valproic Acid 3)

Figure 2 (Valproic Acid 3)
A line graph comparing percent reduction in CPS (clinical parameter) rate against percent of patients for high and low dose groups. It shows two curves labeled High Dose (solid line) and Low Dose (dashed line), with the vertical axis indicating improvement or worsening and the horizontal axis showing percent of patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.